Astonea Labs Board to consider FY26 audited results on May 30
Astonea Labs Limited's Board will meet on May 30, 2026, to approve the standalone and consolidated audited financial results for the financial year ended March 31, 2026. The trading window remains closed until 48 hours post-result declaration.

*this image is generated using AI for illustrative purposes only.
Astonea Labs Limited will convene a Board meeting on May 30, 2026, to consider and approve the audited financial results for the financial year ended March 31, 2026. The meeting will be held at the company's corporate office in Panchkula, Haryana, to review the standalone and consolidated performance for the period.
The Board is scheduled to take up the standalone audited financial results for the half-year and financial year ended March 31, 2026. Additionally, the directors will consider the consolidated audited financial results for the full financial year. The approval of these results is a key regulatory compliance requirement.
In accordance with the Company’s Code of Conduct for Prevention of Insider Trading, the trading window for dealing in the equity shares of Astonea Labs Limited has been closed since April 1, 2026. This restriction will remain in effect until the expiry of 48 hours after the declaration of the audited financial results to the stock exchanges.
The intimation to the stock exchange was filed pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting agenda also includes provisions to take up any other matter with the permission of the Chairman.
Key Meeting Details
| Agenda Item | Details |
|---|---|
| Meeting Date | May 30, 2026 |
| Location | Corporate Office, Panchkula, Haryana |
| Standalone Results | Half-year and FY ended March 31, 2026 |
| Consolidated Results | FY ended March 31, 2026 |
| Trading Window Status | Closed from April 1, 2026 |
Historical Stock Returns for Astonea Labs
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.84% | +21.83% | +74.32% | +86.00% | +105.68% | +105.68% |
How might the upcoming financial results influence investor sentiment and stock volatility once the trading window reopens?
What strategic initiatives or growth drivers does Astonea Labs expect to highlight during the Board meeting?
Could the approval of audited results lead to any dividend declarations or changes in capital allocation policies?

































